What drove GV.PA stock volume after hours today?

The spike to **38,489,238** shares reflects micro-cap liquidity and short-term trader interest rather than a confirmed corporate catalyst. Low float and a tiny market cap mean modest orders cause large volume and price moves.

What is Meyka AI’s price target for GV.PA stock?

Meyka AI's model gives a base-case target **€0.0025** (+38.89%), a bull target **€0.0100** (+455.56%), and a bear target **€0.0010** (-44.44%). These are model projections, not guarantees.

Is GV.PA stock a buy for long-term investors?

GV.PA stock carries high risk due to negative EPS, thin cash reserves, and a small market cap. Meyka AI’s grade is **B (HOLD)**. Long-term investors should wait for clear revenue growth and balance-sheet improvement.

Where can I read company disclosures for Genomic Vision SA?

Official disclosures and product details are on Genomic Vision’s website at [Genomic Vision site](https://www.genomicvision.com). Monitor official filings for financing or commercial updates.

EU Stocks

After Hours Most Active GV.PA Genomic Vision SA: €0.0018 on 38.49M shares signals liquidity

ByHuzaifa Zahoor March 18, 2026

GV.PA stock opened after hours at €0.0018 on 18 Mar 2026 and attracted heavy trading with 38,489,238 shares changing hands. This surge makes Genomic Vision SA (GV.PA) one of the most active names on EURONEXT in the after-hours session. The move follows thin liquidity, a very low market cap of €693,191, and a wide gap between the current price and the 50-day average of €0.00484 and 200-day average of €0.013997. We look at what drove volume, where valuations stand, and how models and analysts frame near-term price targets for GV.PA stock.